Sign up for free insights newsletter
NI

NewGenIvf Group Limited Class A Ordinary Shares

NIVFUnited States

Need professional-grade analysis? Visit stockanalysis.com

$2.17
-6.47%
End of day
Market Cap

$926,478

P/E Ratio

N/A

Employees

N/A

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-1.1528.636.56-0.74-0.804.59
Calmar-7.7210.63-1.01-0.991.17
Sharpe-0.9612.821.71-0.29-0.361.79
Omega0.351.721.790.890.781.11
Martin-13.6319.45-1.17-1.142.64
Ulcer7.286.8040.4383.9186.6260.73

NewGenIvf Group Limited Class A Ordinary Shares (NIVF) Price Performance

NewGenIvf Group Limited Class A Ordinary Shares (NIVF) trades on United States in USD. The company is classified in the Healthcare sector under the Health Care Plans industry. The stock currently trades at $2.17, down 6.47% from the previous close.

Over the past year, NIVF has traded between a low of $0.48 and a high of $282.75. The stock has lost 99.2% over this period. It is currently 99.2% below its 52-week high.

NewGenIvf Group Limited Class A Ordinary Shares has a market capitalization of $926,478.

About NewGenIvf Group Limited Class A Ordinary Shares

NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company provides a range of fertility treatment solutions, including in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sperm analysis, sorting, washing, and freezing, and egg freezing. It also provides IVF treatment; surrogacy and ancillary caring services, including regular body check, as well as vitamins, supplements, and medicines to surrogate mothers; and value-added services comprising nutrition guidance, psychological counselling, acupuncture, and translation interpreters to supplement the IVF treatment. The company offers its services through its clinics. NewGenIvf Group Limited was founded in 2010 and is based in Bangkok, Thailand.

Compare NewGenIvf Group Limited Class A Ordinary Shares

Side-by-side comparison against top Healthcare peers.

Company Info

Exchange
United States
Currency
USD

Financial Metrics

Revenue (TTM)
$5.14M
EBITDA
$-6,801,572
Profit Margin
381.16%
EPS (TTM)
0.26
Book Value
818.78

Technical Indicators

52 Week High
$459.75
52 Week Low
$0.45
50 Day MA
$1.37
200 Day MA
$18.12
Beta
0.00

Valuation

Trailing P/E
0.00
Forward P/E
0.02
Price/Sales
0.20
Price/Book
0.00
Enterprise Value
$2.11M